About CeleCor Therapeutics
CeleCor Therapeutics is a private company based in Del Mar, California. It has reported $58,356,325 raised in four offerings on Form D since May 2017. Its chief executive is Robert Hillman, Ph.D..
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jul 9, 2026 | $11,856,325of $15.0M target | 17 | $697K | EquityRule 506(b) | Form D ↗ |
| Feb 23, 2022 | Mar 8, 2022amended Aug 21, 2024 | $45,500,000fully sold | 11 | $4.1M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| May 3, 2021 | May 10, 2021 | $1,000,000of $5.0M target | 1 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Apr 27, 2017 | May 3, 2017 | $0of $25.0M target | 5 | $0 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $58,356,325 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CeleCor Therapeutics's Form D filed Jul 9, 2026.
Earlier filings also listed Robert Hillman (president, treasurer and director, last listed Aug 2024) and Caspar Sturm (director, last listed May 2017).